Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
S B Saslow, J S Scolapio, M Camilleri, L A Forstrom, G M Thomforde, D D Burton, J Rubin, H C Pitot, A R Zinsmeister
Gut May 1998, 42 (5) 628-634; DOI: 10.1136/gut.42.5.628
